XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (18,407,799) $ (36,893,674)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization 1,059,966 0
Depreciation 685,074 314,334
Stock-based compensation 28,351,975 21,351,212
Stock issued for services 0 353,903
Change in fair value of derivative liabilities (28,669,066) 400
Amortization of debt discount 7,938,229 2,147,594
Amortization of debt discount, related party 0 95,127
Amortization of debt issue costs 0 10,438
Loss on foreign currency exchange 110,538 261,432
Loss on impairment 0 18,119,592
Net (income) loss from investments 1,140,090 (3,420,417)
Other (income) expense, net 2,465,068 (1,268,155)
Income tax (benefit) expense (1,772,804) (5,908,091)
Changes in working capital requirements:    
Accounts receivable (1,899,791) 18,536,022
Accrued revenue 0 (1,717,395)
Inventory (72,779) 14,144
Deposits, prepaids and other current assets (1,761,407) 2,258,191
Other assets (43,147) 117,476
Costs in excess of billings (3,041,310) 0
Accounts payable 10,147,863 (11,205,660)
Other current liabilities (1,196,067) 424,506
Deferred revenue 2,048,463 0
Other comprehensive income 0 (88,023)
Net cash (used in) provided by operating activities (2,916,904) 3,502,956
CASH FLOWS FROM INVESTING ACTIVITIES:    
Acquisition of fixed assets (204,893) (1,274,687)
Disposal of fixed assets 0 837,120
Sale of intellectual property 179,466 0
Purchase of marketable securities (45,430,216) (62,031,435)
Sale of marketable securities 47,428,885 55,872,437
Purchase of non-marketable securities 0 (100,000)
Acquisition of ANS (362,962) (12,948,324)
Acquisition of EV Depot (1,231,250) 0
Cash acquired in acquisition 104,485 (282,101)
Net cash provided by (used in) investing activities 483,515 (19,926,990)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Cash receipts from issuance of notes payable 0 10,000,000
Cash receipts from issuance of convertible notes payable 0 5,000,000
Proceeds from sale of Common Stock 10,000,025 0
Proceeds from sale of Series C Preferred Stock 10,845,000 0
Proceeds from exercise of warrants 1,121,818 0
Proceeds from exercise of stock options 164,076 0
Draws from revolving line of credit, net 254,245 (270,727)
Employee taxes paid for stock-based compensation (417,959) 0
Cash paid for contingent liability 0 (61,232)
Payment on financing lease (78,288) (81,272)
Payment of dividends (818,343) 0
Redemption of Series B Preferred Stock (685,000) 0
Net cash provided by financing activities 20,385,574 14,586,769
Foreign currency adjustment 45,261 (366,306)
NET INCREASE IN CASH AND CASH EQUIVALENTS 17,997,446 (2,203,571)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 18,238,264 11,629,303
CASH AND CASH EQUIVALENTS, END OF PERIOD 36,235,710 9,425,732
Supplemental disclosure of cash flow information    
Cash paid for interest expense 2,138,386 247,900
Cash paid for income taxes 485,401 0
Non-cash investing and financing activities:    
Issuance of Series B Preferred Stock for acquisition 0 6,850,000
Issuance of common stock for acquisition 17,530,278 0
Debt discount associated with promissory notes $ 0 $ 4,296,911